The enormous advances in the immunologic aspects of biotherapeutics and nanomedicines in the past two decades has necessitated an authoritative and comprehensive reference source that can be relied upon by immunologists biomedical researchers clinicians pharmaceutical companies regulators venture capitalists and policy makers alike. This text provides a thorough understanding of immunology therapeutic potential clinical applications adverse reactions and approaches to overcoming immunotoxicity of biotherapeutics and nanomedicines. It also tackles critical yet often overlooked topics such as immune aspects of nano-bio interactions current FDA regulatory guidances complement activation-related pseudoallergy (CARPA) advances in nanovaccines and immunogenicity testing of protein therapeutics. |Immune Aspects of Biopharmaceuticals and Nanomedicines | Science Client Lines
